These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2. Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625 [TBL] [Abstract][Full Text] [Related]
4. Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection. Martin-Gayo E; Yu XG Front Immunol; 2019; 10():1306. PubMed ID: 31244850 [TBL] [Abstract][Full Text] [Related]
5. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles. Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762 [TBL] [Abstract][Full Text] [Related]
6. Innate signaling in HIV-1 infection of dendritic cells. van der Vlist M; van der Aar AM; Gringhuis SI; Geijtenbeek TB Curr Opin HIV AIDS; 2011 Sep; 6(5):348-52. PubMed ID: 21743322 [TBL] [Abstract][Full Text] [Related]
7. Innate immune sensing of HIV infection. Silvin A; Manel N Curr Opin Immunol; 2015 Feb; 32():54-60. PubMed ID: 25617674 [TBL] [Abstract][Full Text] [Related]
8. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cell dysregulation during HIV-1 infection. Miller E; Bhardwaj N Immunol Rev; 2013 Jul; 254(1):170-89. PubMed ID: 23772620 [TBL] [Abstract][Full Text] [Related]
10. Effective innate immune response in natural HIV-1 controllers. Can mimicking lead to novel preventive and cure strategies against HIV-1? Calvet-Mirabent M; Martín-Gayo E Curr Opin HIV AIDS; 2022 Sep; 17(5):308-314. PubMed ID: 35938465 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes. Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047 [TBL] [Abstract][Full Text] [Related]
12. Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection. Huang J; Al-Mozaini M; Rogich J; Carrington MF; Seiss K; Pereyra F; Lichterfeld M; Yu XG Retrovirology; 2012 Jan; 9():11. PubMed ID: 22289474 [TBL] [Abstract][Full Text] [Related]
14. Antiviral immune responses by human langerhans cells and dendritic cells in HIV-1 infection. van den Berg LM; Geijtenbeek TB Adv Exp Med Biol; 2013; 762():45-70. PubMed ID: 22975871 [TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients. Papasavvas E; Foulkes A; Yin X; Joseph J; Ross B; Azzoni L; Kostman JR; Mounzer K; Shull J; Montaner LJ Immunology; 2015 Jul; 145(3):380-90. PubMed ID: 25684333 [TBL] [Abstract][Full Text] [Related]
16. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T cell activation. Rodriguez-Plata MT; Urrutia A; Cardinaud S; Buzón MJ; Izquierdo-Useros N; Prado JG; Puertas MC; Erkizia I; Coulon PG; Cedeño S; Clotet B; Moris A; Martinez-Picado J J Immunol; 2012 Jun; 188(12):6036-45. PubMed ID: 22581857 [TBL] [Abstract][Full Text] [Related]
18. Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles. Hamimi C; David A; Versmisse P; Weiss L; Bruel T; Zucman D; Appay V; Moris A; Ungeheuer MN; Lascoux-Combe C; Barré-Sinoussi F; Muller-Trutwin M; Boufassa F; Lambotte O; Pancino G; Sáez-Cirión A; PLoS One; 2016; 11(8):e0160251. PubMed ID: 27505169 [TBL] [Abstract][Full Text] [Related]
19. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related]